Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.
Whittle SB, Offer K, Roberts RD, LeBlanc A, London C, Majzner RG, Huang AY, Houghton P, Alejandro Sweet Cordero E, Grohar PJ, Isakoff M, Bishop MW, Stewart E, Slotkin EK, Greengard E, Borinstein SC, Navid F, Gorlick R, Janeway KA, Reed DR, Hingorani P.
Whittle SB, et al. Among authors: roberts rd.
Pediatr Blood Cancer. 2021 Sep;68(9):e29188. doi: 10.1002/pbc.29188. Epub 2021 Jun 16.
Pediatr Blood Cancer. 2021.
PMID: 34137164
Free PMC article.